Cisapride treatment for preterm infants

被引：0
|
作者：
Craig J.S. [1 ]
Tubman T. [1 ]
McClure B.G. [1 ]
机构：
[1] Dept of Child Health, The Queen's University of Belfast
来源：
Pediatric Research | 1998年 / 44卷 / 3期
关键词：
D O I：
10.1203/00006450-199809000-00076
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：426 / 426
相关论文
共 50 条
  • [21] QTc interval in infants treated with cisapride
    Kikkert, MA
    Dubin, AM
    Mirmiran, M
    Ariagno, RL
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 45A - 45A
  • [22] Prolongation of QTc in infants treated with cisapride
    Dubin, AM
    Van Hare, GF
    Mirmiran, M
    Baldwin, RB
    Ariagno, RL
    [J]. PEDIATRIC RESEARCH, 1999, 45 (04) : 22A - 22A
  • [23] Cisapride: no arrhythmias or conduction defects in infants
    [J]. Reactions Weekly, 2000, 791 (1) : 5 - 5
  • [24] EFFECT OF CISAPRIDE ON EXCESSIVE REGURGITATION IN INFANTS
    VANEYGEN, M
    VANRAVENSTEYN, H
    [J]. CLINICAL THERAPEUTICS, 1989, 11 (05) : 669 - 677
  • [25] 24-hour electrocardiogram before and during cisapride treatment in neonates and infants
    Zamora, SA
    Belli, DC
    Friedli, B
    Jaeggi, E
    [J]. BIOLOGY OF THE NEONATE, 2004, 85 (04): : 229 - 236
  • [26] GASTROESOPHAGEAL REFLUX AND CHRONIC RESPIRATORY-DISEASE IN INFANTS AND CHILDREN - TREATMENT WITH CISAPRIDE
    OLAFSDOTTIR, E
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 : 32 - 34
  • [27] Nasal high flow treatment in preterm infants
    Calum T. Roberts
    Kate A. Hodgson
    [J]. Maternal Health, Neonatology and Perinatology, 3 (1)
  • [28] Treatment of extremely preterm infants: parents' attitudes
    Hansen, BM
    Hoff, B
    Greisen, G
    [J]. ACTA PAEDIATRICA, 2003, 92 (06) : 715 - 720
  • [29] SEQUELAE OF CAFFEINE TREATMENT IN PRETERM INFANTS WITH APNEA
    GUNN, TR
    METRAKOS, K
    RILEY, P
    WILLIS, D
    ARANDA, JV
    [J]. JOURNAL OF PEDIATRICS, 1979, 94 (01): : 106 - 109
  • [30] Permanent Surgical Treatment for Posthemorrhagic in Preterm Infants
    Harada, Atsuko
    [J]. JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2023, 66 (03) : 281 - 288
12345